Sign in

CIK 0001000694

  • Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222816046
Phone
+1 240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 22,429 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 11,378 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, Research & Development gave up 11,313 shares (to pay taxes)
  4. 4 Shares withheld for taxes President and CEO gave up 38,450 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 28,366 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, Chief Strategy Officer gave up 16,344 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 1,214 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 39,132 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 12,713 shares (to pay taxes)
  10. 4 Shares withheld for taxes Section 16 gave up 6,048 shares (to pay taxes)
  11. 4 Exercise or conversion Director acquired 3,800 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
  19. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)
  20. 4 Exercise or conversion Director acquired 10,420 shares (option exercise)

Page 2 of 38 · 752 filings